0001626199-14-000001.txt : 20141125 0001626199-14-000001.hdr.sgml : 20141125 20141124181946 ACCESSION NUMBER: 0001626199-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141125 DATE AS OF CHANGE: 20141124 EFFECTIVENESS DATE: 20141125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: N30 Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001626199 IRS NUMBER: 208969493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-228991 FILM NUMBER: 141247437 BUSINESS ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-945-7700 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 D 1 primary_doc.xml X0707 D LIVE 0001626199 N30 Pharmaceuticals, Inc. 3122 STERLING CIRCLE, SUITE 200 BOULDER CO COLORADO 80301 720-945-7700 DELAWARE N30 Pharmaceuticals, LLC None Corporation true Howard Furst 3122 Sterling Circle, Suite 200 Boulder CO COLORADO 80301 Director Evan Loh 3122 Sterling Circle, Suite 200 Boulder CO COLORADO 80301 Director Joseph Loscalzo 3122 Sterling Circle, Suite 200 Boulder CO COLORADO 80301 Director John Moore 3122 Sterling Circle, Suite 200 Boulder CO COLORADO 80301 Director Jonathan Leff 3122 Sterling Circle, Suite 200 Boulder CO COLORADO 80301 Director Tom Sokolowski 3122 Sterling Circle, Suite 200 Boulder CO COLORADO 80301 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2014-11-18 false true false 0 40000000 30000000 10000000 false 12 0 845624 Plus the issuance of 288,596 shares of Preferred Stock 0 false N30 Pharmaceuticals, Inc. /s/Tom Sokolowski Tom Sokolowski Chief Financial Officer 2014-11-24